Novel approaches for targeting the adenosine A2A receptor

Area of Science:

• Structural biology
• Drug discovery
• Pharmacology

Background:

• The adenosine A2A receptor (A2AR) is a significant drug target for diseases like cancer, inflammation, Parkinson's, and cardiovascular conditions.
• Advancements in protein stabilization techniques have enabled detailed structural insights into the A2AR.

Purpose of the Study:

• To review the evolution of strategies for targeting the A2AR.
• To highlight key modulators identified through various drug design approaches.

Main Methods:

• Review of adenosine receptor structures, homology modeling, and X-ray crystallography.
• Integration of biophysical methods, fragment-based drug design (FBDD), and in silico screening.
• Discussion of stabilization techniques for protein crystallization and structure determination.

Main Results:

• X-ray crystal structures provide static and dynamic perspectives of the A2AR.
• Fragment-based drug design (FBDD) combined with biophysical methods is a standard approach.
• Hybrid in silico and biophysical screening methods accelerate A2AR ligand discovery.

Conclusions:

• The A2AR remains an attractive target for multiple disease areas.
• Novel stabilization and structural analysis methods have overcome limitations of traditional screening.
• These advanced methods are expected to be applied to other G-protein-coupled receptors.